Avidity Biosciences Inc. (RNA)

29.20

-1.44 (-4.70%)

At close: Mar 03, 2025, 3:59 PM

29.22

0.05%

After-hours: Mar 03, 2025, 04:00 PM EST

Avidity Biosciences Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-322.3M	-212.22M	-174M	-118.01M	-44.35M	-24.73M	-11.22M
Depreciation & Amortization	-18.67M	2.1M	1.39M	639K	373K	348K	383K
Stock-Based Compensation	51.36M	38.22M	27.14M	17.06M	4.31M	406K	60K
Other Working Capital	n/a	59.36M	-8.5M	-705K	-3.42M	18.67M	671K
Other Non-Cash Items	-11.26M	-8.3M	-615K	163K	139K	7.35M	447K
Deferred Income Tax	n/a	n/a	n/a	n/a	84K	n/a	n/a
Change in Working Capital	n/a	61.13M	9.82M	5.34M	2.33M	19.12M	671K
Operating Cash Flow	-300.87M	-119.06M	-136.27M	-94.81M	-37.12M	2.49M	-9.65M
Capital Expenditures	-7.07M	-4.23M	-2.82M	-3.74M	-1.09M	-235K	-49K
Acquisitions	n/a	n/a	187.13M	82.52M	n/a	n/a	n/a
Purchase of Investments	-1.43B	-461M	-355.84M	-85.36M	-6.69M	n/a	n/a
Sales Maturities Of Investments	586.4M	335.16M	168.71M	6.58M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-187.13M	-82.52M	-6.69M	n/a	n/a
Investing Cash Flow	-854.2M	-130.07M	-189.96M	-82.52M	-7.79M	-235K	-49K
Debt Repayment	n/a	n/a	n/a	n/a	-4.68M	16.65M	4.98M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-106K	n/a
Other Financial Acitivies	1.19B	33.32M	1.39M	1.64M	2.67M	72.69M	162K
Financial Cash Flow	1.19B	93.86M	346.17M	176.32M	272.04M	89.23M	5.14M
Net Cash Flow	37.29M	-155.27M	19.95M	-1.01M	227.13M	91.49M	-4.56M
Free Cash Flow	-307.94M	-123.29M	-139.09M	-98.55M	-38.21M	2.25M	-9.7M